Research progress of mucormycosis in burns

Shen Tuo; Zhu Feng

doi:10.3760/cma.j.cn501225-20231101-00165

Volume 39 Issue 12

Dec. 2023

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF BURNS AND WOUNDS > 2023 > 39(12): 1195-1200

Shen T,Zhu F.Research progress of mucormycosis in burns[J].Chin J Burns Wounds,2023,39(12):1195-1200.DOI: 10.3760/cma.j.cn501225-20231101-00165.

Citation:

Shen T,Zhu F.Research progress of mucormycosis in burns[J].Chin J Burns Wounds,2023,39(12):1195-1200.DOI: 10.3760/cma.j.cn501225-20231101-00165.

Citation:

Shen T,Zhu F.Research progress of mucormycosis in burns[J].Chin J Burns Wounds,2023,39(12):1195-1200.DOI: 10.3760/cma.j.cn501225-20231101-00165.

PDF( 852 KB)

Research progress of mucormycosis in burns

doi: 10.3760/cma.j.cn501225-20231101-00165

Shen Tuo¹,
Zhu Feng^{2
,
,}

1.
Department of Critical Care Medicine, Shanghai East Hospital Affiliated to Tongji University, Shanghai 200120, China
2.
Burn Department, the First Affiliated Hospital, Naval Medical University, Shanghai 200433, China

Funds:

National Key Research and Development Program "Stem Cell and Transformation Research" Key Special Project 2019YFA0110602

More Information

Corresponding author: Zhu Feng, Email: alexzhufeng0816@vip.sina.com
Received Date: 2023-11-01
Available Online: 2023-12-19

Abstract

Abstract

Mucormycosis is a relatively rare but dangerous infectious diseases. Burn patients, especially severe burn patients, are at high risk of mucormycosis. In recent years, the incidence of mucormycosis in burn patients has increased. At present, there are a few domestic literatures on mucormycosis in burns, with most being case reports without systematic summary. Based on the relevant literature at home and abroad in recent years, this article reviewed the epidemiological characteristics, clinical manifestations, diagnostic methods, and treatment methods of mucormycosis in burns, hoping to provide some basis for the diagnosis and treatment of mucormycosis in burns in China.
- Burns,
- Invasive fungal infections,
- Mucormycosis,
- Diagnosis,
- Treatment

FullText(HTML)

References(37)

References

[1]	SoboutiB, DahmardeheiM, FallahS, et al. Candidemia in pediatric burn patients: risk factors and outcomes in a retrospective cohort study[J]. Curr Med Mycol, 2020, 6(3):33-41. DOI: 10.18502/cmm.6.3.4663.
[2]	DangJ, GoelP, ChoiKJ, et al. Mucormycosis following burn injuries: a systematic review[J]. Burns, 2023,49(1):15-25. DOI: 10.1016/j.burns.2022.05.012.
[3]	FréalleE, RocchiS, BacusM, et al. Real-time polymerase chain reaction detection of Lichtheimia species in bandages associated with cutaneous mucormycosis in burn patients[J]. J Hosp Infect, 2018,99(1):68-74. DOI: 10.1016/j.jhin.2018.02.004.
[4]	FarmerAR, MurrayCK, DriscollIR, et al. Combat-related pythium aphanidermatum invasive wound infection: case report and discussion of utility of molecular diagnostics[J]. J Clin Microbiol, 2015,53(6):1968-1975. DOI: 10.1128/JCM.00410-15.
[5]	HospenthalDR, ChungKK, LairetK, et al. Saksenaea erythrospora infection following combat trauma[J]. J Clin Microbiol, 2011,49(10):3707-3709. DOI: 10.1128/JCM.05095-11.
[6]	DevauchelleP, JeanneM, FréalleE. Mucormycosis in burn patients[J]. J Fungi (Basel), 2019, 5(25):1-12.DOI: 10.3390/jof5010025.
[7]	JeongW, KeighleyC, WolfeR, et al. The epidemiology and clinical manifestations of mucormycosis: a systematic review and meta-analysis of case reports[J]. Clin Microbiol Infect, 2019,25(1):26-34. DOI: 10.1016/j.cmi.2018.07.011.
[8]	LittlehalesE, TeagueR, AndrewD, et al. Mucormycosis in burns: a review[J]. J Burn Care Res, 2022,43(2):353-360. DOI: 10.1093/jbcr/irab236.
[9]	MitchellTA, HardinMO, MurrayCK, et al. Mucormycosis attributed mortality: a seven-year review of surgical and medical management[J]. Burns, 2014,40(8):1689-1695. DOI: 10.1016/j.burns.2014.03.013.
[10]	RibeiroNF, HeathCH, KierathJ, et al. Burn wounds infected by contaminated water: case reports, review of the literature and recommendations for treatment[J]. Burns, 2010,36(1):9-22. DOI: 10.1016/j.burns.2009.03.002.
[11]	ChristiaensG, HayetteMP, JacqueminD, et al. An outbreak of Absidia corymbifera infection associated with bandage contamination in a burns unit[J]. J Hosp Infect, 2005,61(1):88. DOI: 10.1016/j.jhin.2004.12.011.
[12]	BakerRD. Pulmonary mucormycosis[J]. Am J Pathol,1956,32(2):287-313.
[13]	FoleyFD, ShuckJM3rd, FishbeinMC, et al. Burn-wound infection with phycomycetes requiring amputation of hand[J]. JAMA, 1968, 203(8):596. DOI: 10.1001/jama.1968.03140080056017.
[14]	Garcia-HermosoD, CriscuoloA, LeeSC, et al. Outbreak of invasive wound mucormycosis in a burn unit due to multiple strains of Mucor circinelloides f. circinelloides resolved by whole-genome sequencing[J]. mBio, 2018, 9(2):e00573-18. DOI: 10.1128/mBio.00573-18.
[15]	SchaalJV, LeclercT, SolerC, et al. Epidemiology of filamentous fungal infections in burned patients: a French retrospective study[J]. Burns, 2015,41(4):853-863. DOI: 10.1016/j.burns.2014.10.024.
[16]	ReidG, LynchJP, FishbeinMC, et al. Mucormycosis[J]. Semin Respir Crit Care Med, 2020,41(1):99-114. DOI: 10.1055/s-0039-3401992.
[17]	SatiH, BeardsleyJ, Alastruey-IzquierdoA, et al. WHO fungal priority pathogens list to guide research development and public health[M]. Geneva: World Health Organization,2022. DOI: 10.13140/RG.2.2.31126.63040.
[18]	李峰,杨红明,王宏伟.烧伤患者毛霉菌侵袭性感染(附4例报告)并文献复习[J/CD].中华损伤与修复杂志(电子版), 2011, 6(3):3.DOI: 10.3877/cma.j.issn.1673-9450.2011.03.012.
[19]	SteinbrinkJM, MiceliMH. Mucormycosis[J]. Infect Dis Clin North Am, 2021,35(2):435-452. DOI: 10.1016/j.idc.2021.03.009.
[20]	CornelyOA, Alastruey-IzquierdoA, ArenzD, et al. Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium[J]. Lancet Infect Dis, 2019,19(12):e405-e421. DOI: 10.1016/S1473-3099(19)30312-3.
[21]	VenkateshD, DandagiS, ChandrappaPR, et al. Mucormycosis in immunocompetent patient resulting in extensive maxillary sequestration[J]. J Oral Maxillofac Pathol, 2018,22(Suppl 1):S112-116. DOI: 10.4103/jomfp.JOMFP_163_17.
[22]	SkiadaA, Lass-FloerlC, KlimkoN, et al. Challenges in the diagnosis and treatment of mucormycosis[J]. Med Mycol, 2018,56(Suppl_1):S93-101. DOI: 10.1093/mmy/myx101.
[23]	ChermetzM, GobboM, RupelK, et al. Combined orofacial aspergillosis and mucormycosis: fatal complication of a recurrent paediatric glioma-case report and review of literature[J]. Mycopathologia, 2016, 181(9/10):723-733. DOI: 10.1007/s11046-016-0021-8.
[24]	DhaliwalHS, SinghA, SinhaSK, et al. Diagnosed only if considered: isolated renal mucormycosis[J]. Lancet, 2015,385(9984):2322. DOI: 10.1016/S0140-6736(15)60730-9.
[25]	KungVL, ChernockRD, BurnhamCD. Diagnostic accuracy of fungal identification in histopathology and cytopathology specimens[J]. Eur J Clin Microbiol Infect Dis, 2018,37(1):157-165. DOI: 10.1007/s10096-017-3116-3.
[26]	MiceliMH, MaertensJ. Role of non-culture-based tests, with an emphasis on galactomannan testing for the diagnosis of invasive aspergillosis[J]. Semin Respir Crit Care Med, 2015, 36(5):650-661. DOI: 10.1055/s-0035-1562892.
[27]	DonnellyJP, ChenSC, KauffmanCA, et al. Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium[J]. Clin Infect Dis, 2020, 71(6):1367-1376. DOI: 10.1093/cid/ciz1008.
[28]	ChamilosG, MaromEM, LewisRE, et al. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer[J]. Clin Infect Dis, 2005,41(1):60-66. DOI: 10.1086/430710.
[29]	HammerMM, MadanR, HatabuH. Pulmonary mucormycosis: radiologic features at presentation and over time[J]. AJR Am J Roentgenol, 2018, 210(4):742-747. DOI: 10.2214/AJR.17.18792.
[30]	JungJ, KimMY, LeeHJ, et al. Comparison of computed tomographic findings in pulmonary mucormycosis and invasive pulmonary aspergillosis[J]. Clin Microbiol Infect, 2015,21(7):684.e11-e18. DOI: 10.1016/j.cmi.2015.03.019.
[31]	IbrahimAS, SpellbergB, WalshTJ, et al. Pathogenesis of mucormycosis[J]. Clin Infect Dis, 2012,54(Suppl 1):S16-22. DOI: 10.1093/cid/cir865.
[32]	AkersKS, RowanMP, NieceKL, et al. Antifungal wound penetration of amphotericin and voriconazole in combat-related injuries: case report[J]. BMC Infect Dis, 2015,15:184. DOI: 10.1186/s12879-015-0918-8.
[33]	LedgardJP, van HalS, GreenwoodJE. Primary cutaneous zygomycosis in a burns patient: a review[J]. J Burn Care Res, 2008,29(2):286-290. DOI: 10.1097/BCR.0b013e31816673b1.
[34]	RodriguezCJ, TribbleDR, MaloneDL, et al. Treatment of suspected invasive fungal infection in war wounds[J]. Mil Med, 2018,183(Suppl_2):S142-146. DOI: 10.1093/milmed/usy079.
[35]	WarkentienT, RodriguezC, LloydB, et al. Invasive mold infections following combat-related injuries[J]. Clin Infect Dis, 2012,55(11):1441-1449. DOI: 10.1093/cid/cis749.
[36]	KontoyiannisDP, LewisRE. How I treat mucormycosis[J]. Blood, 2011,118(5):1216-1224. DOI: 10.1182/blood-2011-03-316430.
[37]	MariaNC, PimjaiN. Deferiprone as adjunctive treatment for patients with invasive mucormycosis: a retrospective case series[J]. Infectious Disease Reports, 2018,10(2):7765. DOI: 10.4081/idr.2018.7765.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(2)

Get Citation

PDF

XML

Article Metrics

Article views (210) PDF downloads(34)

Research progress of mucormycosis in burns

doi: 10.3760/cma.j.cn501225-20231101-00165

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Research progress of mucormycosis in burns

doi: 10.3760/cma.j.cn501225-20231101-00165

Abstract

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

Export File

Citation

Format

Content